These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma. Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333 [TBL] [Abstract][Full Text] [Related]
4. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients. Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050 [TBL] [Abstract][Full Text] [Related]
5. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma. Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732 [TBL] [Abstract][Full Text] [Related]
6. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients. Lin H; Faraklas I; Saffle J; Cochran A J Trauma; 2011 Dec; 71(6):1557-61. PubMed ID: 22027887 [TBL] [Abstract][Full Text] [Related]
7. Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer? Kopelman TR; O'Neill PJ; Pieri PG; Salomone JP; Hall ST; Quan A; Wells JR; Pressman MS Am J Surg; 2013 Dec; 206(6):911-5; discussion 915-6. PubMed ID: 24296098 [TBL] [Abstract][Full Text] [Related]
8. Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis. Farrar JE; Droege ME; Philpott CD; Mueller EW; Ernst NE; Makley AT; Deichstetter KM; Droege CA J Surg Res; 2021 Aug; 264():425-434. PubMed ID: 33848842 [TBL] [Abstract][Full Text] [Related]
9. Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. Malinoski D; Jafari F; Ewing T; Ardary C; Conniff H; Baje M; Kong A; Lekawa ME; Dolich MO; Cinat ME; Barrios C; Hoyt DB J Trauma; 2010 Apr; 68(4):874-80. PubMed ID: 20386282 [TBL] [Abstract][Full Text] [Related]
10. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved. Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274 [TBL] [Abstract][Full Text] [Related]
11. The ATLANTIC study: Anti-Xa level assessment in trauma intensive care. Rakhra S; Martin EL; Fitzgerald M; Udy A Injury; 2020 Jan; 51(1):10-14. PubMed ID: 31679829 [TBL] [Abstract][Full Text] [Related]
12. Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients. Costantini TW; Min E; Box K; Tran V; Winfield RD; Fortlage D; Doucet J; Bansal V; Coimbra R J Trauma Acute Care Surg; 2013 Jan; 74(1):128-33; discussion 134-5. PubMed ID: 23271087 [TBL] [Abstract][Full Text] [Related]
13. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients. Bigos R; Solomon E; Dorfman JD; Ha M J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618 [TBL] [Abstract][Full Text] [Related]
14. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients. Walker CK; Sandmann EA; Horyna TJ; Gales MA Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055 [TBL] [Abstract][Full Text] [Related]
15. Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical Trial. Connelly CR; Van PY; Hart KD; Louis SG; Fair KA; Erickson AS; Rick EA; Simeon EC; Bulger EM; Arbabi S; Holcomb JB; Moore LJ; Schreiber MA JAMA Surg; 2016 Oct; 151(10):e162069. PubMed ID: 27487253 [TBL] [Abstract][Full Text] [Related]
16. Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient. Bickford A; Majercik S; Bledsoe J; Smith K; Johnston R; Dickerson J; White T Am J Surg; 2013 Dec; 206(6):847-51, discussion 851-2. PubMed ID: 24070664 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels Compared with Recommended Thromboprophylaxis and Rates of Clinically Evident Venous Thromboembolism in Surgical Oncology Patients. Kramme K; Sarraf P; Munene G J Am Coll Surg; 2020 Mar; 230(3):314-321. PubMed ID: 31843692 [TBL] [Abstract][Full Text] [Related]
18. Enoxaparin titrated by anti-Xa levels reduces venous thromboembolism in trauma patients. Gates RS; Lollar DI; Collier BR; Smith J; Faulks ER; Gillen JR J Trauma Acute Care Surg; 2022 Jan; 92(1):93-97. PubMed ID: 34561398 [TBL] [Abstract][Full Text] [Related]
19. If some is good, more is better: An enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis. Berndtson AE; Costantini TW; Lane J; Box K; Coimbra R J Trauma Acute Care Surg; 2016 Dec; 81(6):1095-1100. PubMed ID: 27244575 [TBL] [Abstract][Full Text] [Related]
20. Inability to predict subprophylactic anti-factor Xa levels in trauma patients receiving early low-molecular-weight heparin. Imran JB; Madni TD; Clark AT; Rizk P; Huang E; Minshall CT; Taveras LR; Cunningham HB; Eastman AL; Koshy JP; Kacir CD; Cripps MW J Trauma Acute Care Surg; 2018 Nov; 85(5):867-872. PubMed ID: 29985229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]